FCRL2/FcRH2 Antibody (B24) [PE]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-11832PE
Clone B24 was used by HLDA to establish CD designation.
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Flow Cytometry
Label
PE (Excitation = 488 nm, Emission = 575 nm)
Antibody Source
Monoclonal Mouse IgG2a Kappa Clone # B24
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for FCRL2/FcRH2 Antibody (B24) [PE]
Immunogen
DNA-immunization followed by a boost with FCRL2/FcRH2 transfected cells
Specificity
The mouse monoclonal antibody B24 recognizes an extracellular epitope of FCRL2/FcRH2, a transmembrane glycoprotein expressed mainly in mature and memory B cells.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG2a Kappa
Applications for FCRL2/FcRH2 Antibody (B24) [PE]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: FCRL2/FcRH2
Long Name
Fc Receptor-like 2
Alternate Names
CD307b, FcRH2, IFGP4, IRTA4, SPAP1
Gene Symbol
FCRL2
Additional FCRL2/FcRH2 Products
Product Documents for FCRL2/FcRH2 Antibody (B24) [PE]
Product Specific Notices for FCRL2/FcRH2 Antibody (B24) [PE]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...